Psoriasis is a chronic inflammatory disease that can affect skin and joints. Their treatment varies depending on the severity and includes topical and systemic. Among the latter are the immunobiological that target the T cell We report a case that demonstrates the close relationship between psoriasis, lymphoma and biologic therapies
Moderate to severe psoriasis tends to be treated with biological drugs. In recent years, the most wi...
The treatment of psoriasis has undergone a revolution with the advent of biologic therapies, includi...
The connection between malignancy risk and tumor necrosis factor alpha (TNFa) inhibitors is still a ...
Psoriasis is a chronic inflammatory disease that can affect skin and joints. Their treatment varies ...
Psoriasis is a common, chronic, inflammatory disease. Psoriasis has been hypothesized to be associat...
Psoriasis is a common chronic inflammatory disease affecting the skin and joints. Moderate to severe...
Abstract Background Therapeutic biologic agents are uncommonly associated with lymphoma. Case presen...
Psoriasis is a chronic immunologically-based inflammatory skin disease. B-chronic lymphocytic leukem...
Psoriasis is one of the most common autoimmune dermatoses with a chronic relapsing course. Biologic ...
Psoriasis is a chronic immunologically-based inflammatory skin disease. B-chronic lymphocytic leukem...
Abstract During the last decade, different studies have converged to evidence the high prevalence of...
Psoriasis and tuberculosis (TB) are 2 conditions with high prevalence in the general population, oft...
Tumour necrosis factor (TNF)-\u3b1 blocking agents have revolutionized the treatment of psoriasis an...
BACKGROUND: Therapies targeting the T cell-mediated pathology of psoriasis have been found to achiev...
The pathogenesis of psoriasis is quite complex, but there is compelling evidence that T-cell activat...
Moderate to severe psoriasis tends to be treated with biological drugs. In recent years, the most wi...
The treatment of psoriasis has undergone a revolution with the advent of biologic therapies, includi...
The connection between malignancy risk and tumor necrosis factor alpha (TNFa) inhibitors is still a ...
Psoriasis is a chronic inflammatory disease that can affect skin and joints. Their treatment varies ...
Psoriasis is a common, chronic, inflammatory disease. Psoriasis has been hypothesized to be associat...
Psoriasis is a common chronic inflammatory disease affecting the skin and joints. Moderate to severe...
Abstract Background Therapeutic biologic agents are uncommonly associated with lymphoma. Case presen...
Psoriasis is a chronic immunologically-based inflammatory skin disease. B-chronic lymphocytic leukem...
Psoriasis is one of the most common autoimmune dermatoses with a chronic relapsing course. Biologic ...
Psoriasis is a chronic immunologically-based inflammatory skin disease. B-chronic lymphocytic leukem...
Abstract During the last decade, different studies have converged to evidence the high prevalence of...
Psoriasis and tuberculosis (TB) are 2 conditions with high prevalence in the general population, oft...
Tumour necrosis factor (TNF)-\u3b1 blocking agents have revolutionized the treatment of psoriasis an...
BACKGROUND: Therapies targeting the T cell-mediated pathology of psoriasis have been found to achiev...
The pathogenesis of psoriasis is quite complex, but there is compelling evidence that T-cell activat...
Moderate to severe psoriasis tends to be treated with biological drugs. In recent years, the most wi...
The treatment of psoriasis has undergone a revolution with the advent of biologic therapies, includi...
The connection between malignancy risk and tumor necrosis factor alpha (TNFa) inhibitors is still a ...